Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of NPI-002 Intravitreal Implant for the Delay of Cataract Progression in Patients Undergoing Vitrectomy

NCT05026632 is registered in ClinicalTrials.gov with Nacuity Pharmaceuticals, Inc. as lead sponsor.

NCT NCT05026632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05026632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of NPI-002 Intravitreal Implant for the Delay of Cataract Progression in Patients Undergoing Vitrectomy
Lead sponsor
Nacuity Pharmaceuticals, Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
January 27, 2022
Completion date
September 3, 2026
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cataract